Search by Drug Name or NDC

    NDC 69097-0259-02 SOLIFENACINE SUCCINATE 5 mg/1 Details

    SOLIFENACINE SUCCINATE 5 mg/1

    SOLIFENACINE SUCCINATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is SOLIFENACIN SUCCINATE.

    Product Information

    NDC 69097-0259
    Product ID 69097-259_13de71d6-5be1-49ee-b2cf-e3d7c8fd7b45
    Associated GPIs 54100055200320
    GCN Sequence Number 057982
    GCN Sequence Number Description solifenacin succinate TABLET 5 MG ORAL
    HIC3 R1I
    HIC3 Description URINARY TRACT ANTISPASMODIC, M(3) SELECTIVE ANTAG.
    GCN 23276
    HICL Sequence Number 026595
    HICL Sequence Number Description SOLIFENACIN SUCCINATE
    Brand/Generic Generic
    Proprietary Name SOLIFENACINE SUCCINATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name solifenacine succinate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name SOLIFENACIN SUCCINATE
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209839
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0259-02 (69097025902)

    NDC Package Code 69097-259-02
    Billing NDC 69097025902
    Package 30 TABLET in 1 BOTTLE (69097-259-02)
    Marketing Start Date 2019-05-20
    NDC Exclude Flag N
    Pricing Information N/A